National drug pricing regulator NPPA today said it has notified prices of 27 essential formulations, including those used for the treatment of diabetes, blood pressure and pain.
"NPPA has fixed/revised ceiling prices/Retail Prices of 27 scheduled formulations under Drugs (Prices Control) Order, 2013," it said in a statement.
NPPA fixes ceiling price of essential medicines of Schedule I under the Drugs (Prices Control) Order (DPCO) 2013.
Also Read
In respect of medicines that are not under price control, manufacturers are allowed to increase the maximum retail price by 10 per cent annually.
The calculation for essential drugs is based on the simple average of all medicines in a particular therapeutic segment with sales of more than 1 per cent.
Disclaimer: No Business Standard Journalist was involved in creation of this content
